Monday November 23 2009 | Biotechnology feed | All feeds
|
|
Amgenhttp://www.amgen.com Amgen Incorporated, Thousand Oaks CA, United States of America. Over the past quarter century, Amgen has pioneered the methods by which human proteins that play a role in disease processes are identified, isolated, produced in quantity and used as therapeutics. Ticker - New Study Shows Nplate(R) Significantly Reduces Splenectomy Rate and Treatment Failure in Patients With Chronic ITPSunday 7th of June 2009 3:43BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:![]() Browse other news from this organisation: Amgen Related Web-Links(If any, Generated Automatically)![]()
Source PR Newswire |
|